Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 993
Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 754
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer
L.S. Ong, Wee Chyan Lee, Shijun Ma, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 543
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 838-857
Open Access | Times Cited: 513
Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 487
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
Ellen Duong, Tim Fessenden, Emi A. Lutz, et al.
Immunity (2021) Vol. 55, Iss. 2, pp. 308-323.e9
Open Access | Times Cited: 211
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 184
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 173
The STING1 network regulates autophagy and cell death
Ruoxi Zhang, Rui Kang, Daolin Tang
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 156
STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
Yasmine Messaoud‐Nacer, Elodie Culerier, Stéphanie Rose, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 133
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Julia Koerner, Dennis J. Horvath, Valerie L. Herrmann, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses
Isabelle K. Vila, Hanane Chamma, Alizée Steer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 125-139.e8
Open Access | Times Cited: 100
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 80
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Loretah Chibaya, Jarin T. Snyder, Marcus Ruscetti
Seminars in Cancer Biology (2022) Vol. 86, pp. 827-845
Open Access | Times Cited: 72
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
Christian Rolfo, Elisa Giovannetti, Pablo Martínez, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 69
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57
STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2
Liting Zhang, Congqing Jiang, Yunhong Zhong, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 8, pp. 1208-1222
Closed Access | Times Cited: 55
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1212-1224
Open Access | Times Cited: 39
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes B. Fuertes, Carolina I. Domaica, Norberto W. Zwirner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
Type I and II Interferons in the Anti-Tumor Immune Response
Sarah E. Fenton, Diana Saleiro, Leonidas C. Platanias
Cancers (2021) Vol. 13, Iss. 5, pp. 1037-1037
Open Access | Times Cited: 84
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Yang Xun, Hua Yang, Bożena Kamińska, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 82
cGAS-STING signaling in cancer immunity and immunotherapy
Huashan Du, Tianmin Xu, Manhua Cui
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110972-110972
Open Access | Times Cited: 72
The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA
Vijay Kumar
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top